Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents.


Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 11 2021
Historique:
received: 26 07 2021
revised: 21 09 2021
accepted: 03 10 2021
pubmed: 10 10 2021
medline: 8 1 2022
entrez: 9 10 2021
Statut: ppublish

Résumé

A series of nitric oxide (NO) donor furoxan conjugates of N, N-dialkylcarboxy coumarins have been synthesized as potential anticancer agents. The synthesized compounds have been tested for their in vitro antiproliferative activities on various cancer and noncancerous cell lines. The candidate derivatives exhibit selectivity towards cancer cells with excellent activities in low nM to µM concentrations. In vitro mechanistic studies indicate that the candidate compounds generate substantial NO, inhibit colony formation, and cause apoptosis in cancer cells. A preliminary in vivo tolerance study of the lead candidate 10 in mice indicates that it is well-tolerated, evidenced by zero mortality and normal body weight gains in treated mice. Further translation of the lead derivative 10 using MDA-MB-231 based tumor xenograft model shows good tumor growth reduction.

Identifiants

pubmed: 34626786
pii: S0960-894X(21)00638-7
doi: 10.1016/j.bmcl.2021.128411
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Coumarins 0
Nitric Oxide 31C4KY9ESH
coumarin A4VZ22K1WT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

128411

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Grady L Nelson (GL)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Conor T Ronayne (CT)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Lucas N Solano (LN)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Sravan K Jonnalagadda (SK)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Shirisha Jonnalagadda (S)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Tanner J Schumacher (TJ)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Zachary S Gardner (ZS)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.

Hithardha Palle (H)

Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Chinnadurai Mani (C)

Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Jon Rumbley (J)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA; Department of Pharmacy Practice & Pharmaceutical Sciences, University of Minnesota, Duluth, MN 55812, USA.

Venkatram R Mereddy (VR)

Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA; Department of Pharmacy Practice & Pharmaceutical Sciences, University of Minnesota, Duluth, MN 55812, USA; Department of Chemistry and Biochemistry, University of Minnesota Duluth, Duluth, MN 55812, USA. Electronic address: vmereddy@d.umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH